clinical trial · NCT04124614
Brexpiprazole as Combination Therapy With Sertraline in Treatment of Adults With PTSD
Otsuka Pharmaceutical Development & Commercialization, Inc.·phase3·completed·n = 450
Post Traumatic Stress DisorderBrexpiprazoleSertralinePlacebo
brief summary
This will be a 12-week, multicenter, randomized, double-blind trial evaluating the efficacy, safety, and tolerability of brexpiprazole + sertraline combination treatment in adult participants with Post-Traumatic Stress Disorder.
started
Oct 17, 2019
primary completion
Jul 19, 2023
completion
Aug 8, 2023
last updated
Jun 13, 2025
official title
A Phase 3, Multicenter, Randomized, Double-blind Trial of Brexpiprazole as Combination Therapy With Sertraline in the Treatment of Adults With Post-traumatic Stress Disorder
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol